A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery

Objective To compare the efficacy and safety of high-intensity focused ultrasound (HIFU) and radical surgery for non-metastatic pancreatic cancer (PC).Materials and methods We retrospectively analyzed 89 stage I/II/III PC patients who underwent HIFU (n = 43) or surgery (n = 46) at the Third Xiangya...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Yu, Yunfei Liu, Zhiqiang Li, Yanyan Huang, Guangping Tu, Qiuling Shi, Lang Chen, Xiao Yu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2024.2398557
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850083820165922816
author Li Yu
Yunfei Liu
Zhiqiang Li
Yanyan Huang
Guangping Tu
Qiuling Shi
Lang Chen
Xiao Yu
author_facet Li Yu
Yunfei Liu
Zhiqiang Li
Yanyan Huang
Guangping Tu
Qiuling Shi
Lang Chen
Xiao Yu
author_sort Li Yu
collection DOAJ
description Objective To compare the efficacy and safety of high-intensity focused ultrasound (HIFU) and radical surgery for non-metastatic pancreatic cancer (PC).Materials and methods We retrospectively analyzed 89 stage I/II/III PC patients who underwent HIFU (n = 43) or surgery (n = 46) at the Third Xiangya Hospital from January 2020 to December 2021. Pain relief, Karnofsky Performance Scale (KPS), overall survival (OS), treatment-related complications and risk factors for OS were assessed.Results There was no significant difference in the pain relief rate at 30 days post-treatment between the two groups. However, compared with the surgery group, the HIFU group showed significantly lower post-treatment VAS scores (p = 0.019). In the surgery group, the KPS at 30 days post-treatment was lower than pretreatment KPS (70 vs 80; p = 0.015). This relationship was reversed in the HIFU group (80 vs 70; p = 0.024). Median OS favored surgery over HIFU (23 vs 10 months; p < 0.001), with a higher 1-year OS rate (69.57% vs 32.6%; p < 0.001). However, there was no significant difference in OS between the two groups for stage III patients (p = 0.177). Complications rated ≥ grade III were 2.33% in the HIFU group and 32.6% in the surgery group. Multivariate analyses showed that age, KPS, and treatment methods were independent prognostic factors for OS.Conclusion HIFU demonstrates advantages over surgery in terms of early KPS, VAS improvements, and safety for pancreatic cancer; however, long-term outcomes favor surgery. For III-stage disease, HIFU was noninferior to surgery in overall survival.
format Article
id doaj-art-c62ae79ccfac489f9a1384e9bfd2a804
institution DOAJ
issn 0265-6736
1464-5157
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj-art-c62ae79ccfac489f9a1384e9bfd2a8042025-08-20T02:44:12ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2024.2398557A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgeryLi Yu0Yunfei Liu1Zhiqiang Li2Yanyan Huang3Guangping Tu4Qiuling Shi5Lang Chen6Xiao Yu7Department of Hepatopancreatobiliary Surgery, Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Hepatopancreatobiliary Surgery, Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Hepatopancreatobiliary Surgery, Third Xiangya Hospital, Central South University, Changsha, ChinaSchool of Public Health, Chongqing Medical University, Chongqing, ChinaDepartment of Hepatopancreatobiliary Surgery, Third Xiangya Hospital, Central South University, Changsha, ChinaSchool of Public Health, Chongqing Medical University, Chongqing, ChinaDepartment of Hepatopancreatobiliary Surgery, Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Hepatopancreatobiliary Surgery, Third Xiangya Hospital, Central South University, Changsha, ChinaObjective To compare the efficacy and safety of high-intensity focused ultrasound (HIFU) and radical surgery for non-metastatic pancreatic cancer (PC).Materials and methods We retrospectively analyzed 89 stage I/II/III PC patients who underwent HIFU (n = 43) or surgery (n = 46) at the Third Xiangya Hospital from January 2020 to December 2021. Pain relief, Karnofsky Performance Scale (KPS), overall survival (OS), treatment-related complications and risk factors for OS were assessed.Results There was no significant difference in the pain relief rate at 30 days post-treatment between the two groups. However, compared with the surgery group, the HIFU group showed significantly lower post-treatment VAS scores (p = 0.019). In the surgery group, the KPS at 30 days post-treatment was lower than pretreatment KPS (70 vs 80; p = 0.015). This relationship was reversed in the HIFU group (80 vs 70; p = 0.024). Median OS favored surgery over HIFU (23 vs 10 months; p < 0.001), with a higher 1-year OS rate (69.57% vs 32.6%; p < 0.001). However, there was no significant difference in OS between the two groups for stage III patients (p = 0.177). Complications rated ≥ grade III were 2.33% in the HIFU group and 32.6% in the surgery group. Multivariate analyses showed that age, KPS, and treatment methods were independent prognostic factors for OS.Conclusion HIFU demonstrates advantages over surgery in terms of early KPS, VAS improvements, and safety for pancreatic cancer; however, long-term outcomes favor surgery. For III-stage disease, HIFU was noninferior to surgery in overall survival.https://www.tandfonline.com/doi/10.1080/02656736.2024.2398557HIFUpancreatic cancersurgerysurvivalpain reliefKarnofsky Performance Scale
spellingShingle Li Yu
Yunfei Liu
Zhiqiang Li
Yanyan Huang
Guangping Tu
Qiuling Shi
Lang Chen
Xiao Yu
A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery
International Journal of Hyperthermia
HIFU
pancreatic cancer
surgery
survival
pain relief
Karnofsky Performance Scale
title A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery
title_full A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery
title_fullStr A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery
title_full_unstemmed A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery
title_short A retrospective comparative study on the treatment of non-metastatic pancreatic cancer using high-intensity focused ultrasound versus radical surgery
title_sort retrospective comparative study on the treatment of non metastatic pancreatic cancer using high intensity focused ultrasound versus radical surgery
topic HIFU
pancreatic cancer
surgery
survival
pain relief
Karnofsky Performance Scale
url https://www.tandfonline.com/doi/10.1080/02656736.2024.2398557
work_keys_str_mv AT liyu aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT yunfeiliu aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT zhiqiangli aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT yanyanhuang aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT guangpingtu aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT qiulingshi aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT langchen aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT xiaoyu aretrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT liyu retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT yunfeiliu retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT zhiqiangli retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT yanyanhuang retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT guangpingtu retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT qiulingshi retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT langchen retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery
AT xiaoyu retrospectivecomparativestudyonthetreatmentofnonmetastaticpancreaticcancerusinghighintensityfocusedultrasoundversusradicalsurgery